Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

HIV

This page shows the latest HIV news and features for those working in and with pharma, biotech and healthcare.

FDA expecting boom in cell and gene therapies

FDA expecting boom in cell and gene therapies

The move comes in the wake of the furore caused by Chinese scientist He Jiankui whose gene-editing of twin girls to protect them against HIV hit the headlines last year.

Latest news

More from news
Approximately 80 fully matching, plus 488 partially matching documents found.

Latest Intelligence

  • Redefining communications excellence Redefining communications excellence

    In 2016, Gilead broke its self-enforced moratorium on the marketing of Truvada for PrEP, its drug for preventing HIV. ... A separate survey found 57% of resident trainees did not know the local rate of HIV.

  • The race for a HIV ‘cure’ The race for a HIV ‘cure’

    both in the community with HIV and in the general population and health system. ... need to get tested and be treated if found to be HIV positive.

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    At the same time it confronted the fact that pharma has prospered on making drugs which require long-term treatment, eg HIV antiretrovirals, as they produce a long-term revenue stream.

  • Advancing women in healthcare Advancing women in healthcare

    Gerberding’s talent as a doctor and a public health leader first became apparent while working at the frontline of the HIV/AIDs crisis in the 1980s, to leading the US

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    One of the outstanding clinical trialists and epidemiologists of her generation, Prof Janet Darbyshire’s expertise in research methodology has led to improved prevention and treatment of diseases such as HIV

More from intelligence
Approximately 3 fully matching, plus 42 partially matching documents found.

Latest appointments

  • Aelix Therapeutics appoints Dr Thomas Hecht Aelix Therapeutics appoints Dr Thomas Hecht

    its HIV vaccine. ... After decades of work to develop a HIV vaccine, I hope to contribute with my experience in building a strong player that I believe has good chances to be amongst the

  • emotive boosts its client services team emotive boosts its client services team

    Fay Lepley also joins the agency as an account executive and has had experience working in PR and healthcare communications across several therapy areas including cardiovascular, diabetes and HIV.

  • GSK's Deborah Waterhouse to take over from ViiV' Dominique Limet GSK's Deborah Waterhouse to take over from ViiV' Dominique Limet

    GlaxoSmithKline has promoted Deborah Waterhouse to replace ViiV Healthcare's CEO Dominique Limet when he steps down from the HIV-focused firm at the end of March. ... We have delivered scientific innovation, while listening and better understanding the

  • Bionor names executive management team additions Bionor names executive management team additions

    Three new starters including chief operating officer and interim CFO. HIV and deadly virus firm Bionor Pharma has revealed a number of new additions to its executive management team. ... Together, they bring a wealth of experience to advance therapeutic

  • MHP Health strengthens team with four hires MHP Health strengthens team with four hires

    She also volunteers for two HIV charities: one based in London, which supports young people who have family members affected by HIV and one that supports the work of people in

More from appointments
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 31 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Quick links

Infographics

Multimedia